BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 29, 1999
View Archived Issues
One-year NINDS study results on t-PA for acute ischemic stroke
Read More
Ferrer to market Ortec's Composite Cultured Skin in Spain
Read More
PowderJect development update and preliminary year-end results
Read More
Results announced for CytoTherapeutics' pain control implant study
Read More
Antiarrhythmic drug to move into phase II trials at CV Therapeutics
Read More
BioCryst receives milestone payment from Ortho-McNeil
Read More
Fosamax receives FDA approval for glucocorticoid-induced osteoporosis
Read More
Magainin begins phase II testing of squalamine
Read More
News from ADA: pentoxifylline improves insulin sensitivity in patients with poor glycemic control
Read More
Ligand submits NDA for Targretin capsules and reports positive interim data from psoriasis study
Read More
The nontriptan antimigraine agent SB-220453 has a novel mechanism, no vasoconstrictor activity
Read More
SA-6541 effective in animal models of arthritis and dermatitis, as reported at ongoing congress
Read More
Roberts buys rights to Agrylin from Bristol-Myers Squibb
Read More
Orphan Medical's Antizol injection receives approval in the U.K.
Read More
Adenosine binding and uptake inhibitors in the Kyowa Hakko pipeline
Read More
Sumitomo presents new inhibitors of STAT6 activation
Read More
Antiischemic and cytoprotective agents from Taisho act via inhibition of Na+/Ca2+ exchange
Read More
Continued focus at Merck on inhibitors of protein farnesyltransferase
Read More
Frovatriptan shows excellent efficacy and safety in thousands of patients treated
Read More
IntraBiotics prepares safer new threonine-containing protegrin peptide antibiotics
Read More
3M presents new inhibitors of 5-LO and their use
Read More
Substituted imidazoles for glaucoma, pain, etc., in early development at Allergan
Read More
Effective and safe antiinflammatory agent with dual mechanism of action presented at congress
Read More
24-hour headache recurrence is significantly lower with eletriptan than with other triptans
Read More
Preclinical profile suggests that cipamfylline is a promising candidate for atopic dermatitis
Read More
Ares-Serono's Gonal-F receives E.U. approval as treatment of male infertility
Read More
Bradykinin mimic reduces myocardial infarct size in rat model
Read More
S-33516: promising new COX-2-selective antiinflammatory for rheumatic diseases
Read More
Data presented at World Congress on Inflammation suggest potential of adefovir in RA
Read More
Antiinflammatory mechanism(s) of orazipone undergoes study at Orion
Read More